The variable role of inflammation in acute coronary syndromes and in restenosis.
Inflammation has recently been shown to be an important pathogenetic component of atherosclerosis in general and of acute coronary syndromes in particular. Not only activated inflammatory cells have been found in the plaques, but, more interestingly, also activated circulating inflammatory cells as well as elevated levels of systemic markers of inflammation have been described. Among these, C-reactive protein is of clinical value, as its levels are associated with the outcome. Inflammation is important also in triggering the mechanisms of restenosis and CRP has been recently described as a useful pre-procedure marker of risk of restenosis. The cause of inflammation, what triggers the shift from an indolent disease to the acute coronary syndromes and the more appropriate therapies are still a matter of debate.
Biasucci
L M
LM
Istituto di Cardiologia, Universita' Cattolica del Sacro Cuore, Roma, Italy. biasucc1@pelagus.it
Liuzzo
G
G
Buffon
A
A
Maseri
A
A
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D015415:Biomarkers / Q000032:analysis; D002097:C-Reactive Protein / Q000032:analysis*; D003324:Coronary Artery Disease / Q000503:physiopathology*; D018450:Disease Progression; D005260:Female; D006801:Humans; D007249:Inflammation / Q000175:diagnosis* / Q000503:physiopathology*; D008297:Male; D009203:Myocardial Infarction / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D017202:Myocardial Ischemia / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy; D011379:Prognosis; D012008:Recurrence; D012680:Sensitivity and Specificity; D013577:Syndrome
D015415:Biomarkers; D002097:C-Reactive Protein